Colchicine in Percutaneous Coronary Intervention
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 714 participants.
Also called NCT02594111
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 714 participants
- Registry
-
NCT02594111
-
- Other papers using this trial's data
- Neutrophil Activation and Adhesiveness in Coronary Artery Disease: Results From the COLCHICINE-PCI Biomarker Substudy
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02594111. Randomized; quadruple masking; primary purpose treatment. Start 2013-05-30 (actual); primary completion 2019-08-30 (actual). Results posted on 2020-07-10.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Colchicine in Percutaneous Coronary Intervention
- Acronym
- Colchicine-PCI
- Condition
- Coronary Artery Disease
- Condition
- Acute Coronary Syndrome
- Intervention (Drug)
- Colchicine vs Placebo
- Lead sponsor
- VA Office of Research and Development
- Collaborator
- NYU Langone Health
Record details
- Record id
cardio:ct-nct02594111- Content hash
17cbe39cdb9a23d275890a56db79da011024dbe420f6522569473ea94e2c7f3f